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POZylation: a new approach to enhance
nanoparticle diﬀusion through mucosal barriers†
Edward D. H. Mansﬁeld,a Katy Sillence,b Patrick Hole,b Adrian C. Williamsa and
Vitaliy V. Khutoryanskiy*a
The increasing use of nanoparticles in the pharmaceutical industry is generating concomitant interest in
developing nanomaterials that can rapidly penetrate into, and permeate through, biological membranes
to facilitate drug delivery and improve the bioavailability of active pharmaceutical ingredients. Here, we
demonstrate that the permeation of thiolated silica nanoparticles through porcine gastric mucosa can be
signiﬁcantly enhanced by their functionalization with either 5 kDa poly(2-ethyl-2-oxazoline) or poly(ethyl-
ene glycol). Nanoparticle diﬀusion was assessed using two independent techniques; Nanoparticle Track-
ing Analysis, and ﬂuorescence microscopy. Our results show that poly(2-ethyl-2-oxazoline) and poly
(ethylene glycol) have comparable abilities to enhance diﬀusion of silica nanoparticles in mucin disper-
sions and through the gastric mucosa. These ﬁndings provide a new strategy in the design of nanomedi-
cines, by surface modiﬁcation or nanoparticle core construction, for enhanced transmucosal drug
delivery.
1. Introduction
The field of nanomedicine has expanded rapidly over the past
decade, with over 3500 publications in 2014 alone. Indeed
some nano-scale formulations are currently marketed, includ-
ing Abraxane,1 and Doxil,2 with many others, such as C-Dots,3
undergoing clinical trials. Nanomedicines are advantageous as
they typically penetrate deeper into tissue and membranes
than larger micro- or macro-sized particles, allowing them to
readily distribute throughout the body, leading to a greater
eﬃciency of drug delivery.4–6 However, in order to achieve this,
the particles must first cross the body’s defensive barriers, for
example the mucosal membranes.
Mucus is a biological gel that coats tissue surfaces generally
exposed to the external environment such as the airways, GI
tract, eyes and reproductive tract. It forms a defensive barrier
that captures or blocks foreign bodies and pathogenic bacteria
from reaching the underlying cells and causing damage or
disease. Mucus is predominantly comprised of water (around
95%), glycoproteins (2–5%), lipids, and salts. The glycosylated
proteins are from the MUC family, and are more commonly
known as mucins. However, their functionality varies depend-
ing on bodily location,7–9 and on the disease state of the
system, leading to diﬀerences in rheological properties.10 In
some routes of drug administration, such as oral, nasal, pul-
monary or vaginal, mucus acts as a barrier and therefore drugs
and/or drug vehicles need to be specifically designed to pene-
trate this layer before they are removed via mucus clearance.11
Enhancing mucosal penetration and permeation is therefore
essential to avoid capture and excretion from the mucosal
barrier, and to fully exploit the benefits of nanoparticle-based
drug delivery.
Recently, Hanes et al.12 reported that the diﬀusion of
200 nm polystyrene nanoparticles through mucus gels could
be facilitated by PEGylation. Subsequent reports describe the
mucopenetrative properties of other nanomaterials coated
with poly(vinyl alcohol).13,14
Previously, we have shown that PEGylation of thiolated
silica nanoparticles decreased their mucoadhesion onto intact
corneae,15 and facilitated their penetration into de-epithelia-
lized corneae.16 PEGylation of silica nanoparticles reduces the
adhesive interactions with collagen fibers in the stroma, due
to the “stealth” properties of poly(ethylene glycol) (PEG), and
so enhances penetration.
Here, we report for the first time the use of poly(2-ethyl-2-
oxazoline) (POZ) to facilitate the diﬀusion of the nanoparticles
in porcine gastric mucin dispersions, and into ex vivo porcine
gastric mucosa. POZ has recently attracted a great deal of
attention as a non-ionic polymer that exhibits many useful
physicochemical properties, biocompatibility and “stealth” be-
haviour similar to those of PEG.17–23 However, to the best of
our knowledge, there have been no previous reports exploring
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c5nr03178h
aSchool of Pharmacy, University of Reading, PO Box 224, Whiteknights, Reading,
Berkshire RG6 6AD, UK. E-mail: v.khutoryanskiy@reading.ac.uk
bMalvern Instruments Limited, London Road, Amesbury, Wiltshire SP4 7RT, UK
This journal is © The Royal Society of Chemistry 2015 Nanoscale, 2015, 7, 13671–13679 | 13671
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
Ju
ly
 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
6/
08
/2
01
5 
10
:1
9:
28
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal  | View Issue
POZylation to facilitate the diﬀusion of nanomaterials through
mucosal barriers.
In the current work, the surface of 50 nm thiolated silica
nanoparticles was successfully functionalized with 5 kDa POZ
and PEG using thiol–alkyne and thiol–maleimide click reac-
tions, respectively. The diﬀusion of parent and functionalized
nanoparticles in porcine gastric mucin dispersions was
studied using Nanoparticle Tracking Analysis (NTA). Previously
NTA has only been used to assess the diﬀusive properties of
nanoparticles in solutions of synthetic polymers and neutral
polysaccharides.24 Additionally, a fluorescent microscopy tech-
nique, combined with image analysis, was developed to study
the penetration of parent and functionalized nanoparticles
into ex vivo porcine gastric mucosa. The results show that both
PEG and POZ enhance the diﬀusion of nanoparticles in both
porcine gastric mucin dispersions and through ex vivo gastric
mucosa. Considering the significant advantages of POZ in
comparison to PEG (i.e. ease in synthesis,20 high degree of
renal clearance, and lack of bioaccumulation17) POZylation is a
highly promising strategy to enhance the penetration of nano-
materials through mucosal barriers.
2. Materials and methods
2.1 Materials
3-Mercaptopropyltrimethoxysilane (MPTS), maleimide termi-
nated poly(ethylene glycol) 5 kDa (PDI ≤ 1.1), alkyne termi-
nated poly(2-ethyl-2-oxazoline) 5 kDa (PDI ≤ 1.2), tri-ethyl
amine (TEA), and porcine gastric mucin type II were purchased
from Sigma-Aldrich (Gillingham, UK). BODIPY C5 TMR malei-
mide was purchased from Invitrogen (UK). Dimethyl sulfoxide
(DMSO) and fluorescein-O-methacrylate was purchased from
Fisher Scientific (UK). All water used in this study was ultra-
pure from a Purelab UHQ water filter (18 Ω). All other reagents
were of analytical grade or higher, purchased from Sigma-
Aldrich, unless otherwise stated.
2.2 Core nanoparticle synthesis
Thiolated silica nanoparticles were synthesised according to a
previously described protocol.15,24 Briefly, 0.75 mL MPTS was
mixed with 20 mL DMSO, and 0.5 mL NaOH (0.5 mol L−1).
The mixture was bubbled through with air to facilitate partial
oxidation of thiol groups and formation of disulphide bonds.
The reaction was left for 24 hours at room temperature under
continuous stirring. After the reaction was complete, nano-
particle suspensions were dialysed against 4 L deionised water
for 48 hours using cellulose dialysis membrane (molecular
weight cut oﬀ 12–14 kDa, Medicell International Ltd, UK). The
water was changed every 2 hours.
2.3. Determination of free thiol groups on nanoparticle surfaces
Ellman’s assay was used to quantify the amount of reactive
thiol groups present on nanoparticle surfaces. The procedure
utilised was that of Bravo-Osuna25 with minor modifications.
Prior to the assay, 1 mL of nanoparticle suspension was freeze-
dried using a Heto PowerDry LL3000 freeze drier, and the
weight recorded before and after in order to determine concen-
tration of particles (mg mL−1). Then, 3 mg of dry particles
were re-suspended in 10 mL phosphate buﬀer (pH 8, 0.5 mol
L−1), and allowed to incubate for 1 hour. 10 aliquots (0.5 mL)
were individually placed in Eppendorf vials and reacted with
0.5 mL 5,5′-dithiobis-(2-nitrobenzoic acid) (0.3 mg mL−1) for
2 hours in the dark. 200 µL aliquots were then pipetted into a
96 well plate (three repeats for each Eppendorf vial), and the
absorbance measured at 420 nm using a BioTek Epoch plate
reader. L-Cysteine–HCl solutions were used as standards in the
concentration range of 3.125 µM to 12.69 µM, and reacted
under the same conditions as for the nanoparticles.
2.4 Fluorescent labelling of nanoparticles
Two diﬀerent fluorescent probes were used in this study. For
NTA analysis, nanoparticles were labelled with BODIPY TMR
C5 maleimide (excitation 544 nm, emission 570 nm) (Life
Technologies Ltd, Paisley, UK), and for stomach mucosa pene-
tration studies, fluorescein-O-methacrylate (excitation 490 nm,
emission 520 nm) was used.
Based on the results of the Ellman’s assay, nanoparticles
were labelled with fluorophore, so that only 5% of the free
thiol groups had reacted, leaving 95% free for polymer
functionalisation. This loading was selected from an optimi-
sation study wherein a series of increasingly fluorescent nano-
particles were produced, their fluorescence spectra determined
and compared to that of a 1% w/v mucus suspension; 5%
labelling was suﬃcient to ensure that the particles were detect-
able beyond the background fluorescence of mucin (Fig. 1s†).
Therefore, 380 µL BODIPY (1.8 mM) was reacted with each
5 mL suspension of nanoparticles (19 ± 3 mg mL−1). The
fluorophore and nanoparticles were reacted for 24 hours in the
dark, and then purified by dialysis (again in the dark), as
described in 2.2.
For fluorescein labelling, fluorescein-O-methacrylate was
initially dissolved in a 50 : 50% v/v ethanol–deionised water
solution, to a final fluorescein concentration of 1.8 mM.
Additionally, a 5 mL nanoparticle suspension (19 ± 3 mg
mL−1) was diluted with 5 mL DMSO. Following this, 2 mL of
fluorescein-O-methacrylate solution was added (so the final
concentration of fluorescein-O-methacrylate in the reaction
mixture was 0.066 mM), along with 200 µL TEA (0.033 mM
final concentration). The reaction was left to stir in a flask for
24 hours in the dark. Particles were purified by dialysis once
the reaction was complete, as described in 2.2.
2.5 PEGylation and POZylation of nanoparticles
Two diﬀerent polymers were used to functionalise the silica
nanoparticles; 5 kDa PEG and 5 kDa POZ. Maleimide termi-
nated PEG (100 mg) was added to a 5 mL suspension of fluor-
escently labelled nanoparticles (19 ± 3 mg mL−1), and left to
react under constant stirring for 24 hours in the dark. Samples
were purified by dialysis as in 2.2. Similarly, alkyne terminated
POZ (100 mg) was added to a 5 mL suspension of fluorescent
nanoparticles (19 ± 3 mg mL−1), which had been diluted with
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5 mL DMSO prior to the reaction. Following this, 200 µL TEA was
added, and the reaction left for 24 hours under constant stirring
in the dark. TEA was previously reported to facilitate thiol–yne
click reactions.26 Again, the samples were purified by dialysis.
2.6 Nanoparticle characterisation
The sizes of all nanoparticle samples (parent thiolated silica,
PEGylated silica and POZylated silica) were characterised using
dynamic light scattering (DLS) and nanoparticle tracking ana-
lysis (NTA). Additionally, surface functionality was confirmed
using Fourier transform infrared spectroscopy (FTIR) and
FT-Raman spectroscopy.
DLS measurements used a Zetasizer Nano-ZS (Malvern,
UK). Samples were diluted 1 : 100 into ultrapure water to
appropriate concentrations in low volume plastic cuvettes
(Fisher Scientific). A refractive index of 1.49 and absorbance of
0.01 was used for all measurements. Individual measurements
were carried out for 10 seconds per run, with 12 runs per
reading, repeated in triplicate. This was repeated for 3 separate
samples at 25 °C. ξ-Potential values were also measured, using
DTS-1061 folded capillary tube cuvettes (Malvern, UK).
Samples were prepared to the same concentration as used in
sizing experiments. Samples were measured using 20 sub-runs
per reading, repeating 3 times for each sample. Each sample
was measured three times and the results were processed
using the Smoluchowski model (Fκa = 1.50).
NTA measurements used a LM10 system with LM14 laser
module and top plate, and green 532 nm laser (Malvern, UK).
NTA requires very low concentrations of nanoparticles in sus-
pension, as each nanoparticle is individually tracked. Therefore,
samples were diluted 1 : 1 000 000 from the stock solution.
Samples were then placed in a 1 mL syringe and loaded into the
system. The syringe was placed into an NTA syringe pump set to
move at a flow rate of 30 AU. Videos were recorded for 60
seconds, and 5 videos were made per individual sample, and 3
samples were measured in total. Analysis was carried out using
NTA v3.0. All NTA sizing experiments were at room temperature
(25 °C) under the constant syringe pump flow, to obtain data
representative of all particles in the sample.
Freeze-dried samples were used for all spectroscopic ana-
lyses. FTIR spectra were recorded using a Spectrum 100 FTIR
spectrophotometer (Perkin-Elmer, UK). Samples were
measured for an average of 14 scans, between 4000 and
650 cm−1, at a resolution of 4 cm−1.
FT-Raman spectra were recorded on a Nicolet NXR 9650
Raman spectrophotometer (Thermo Scientific, UK) from an
average of 1000 scans, between 4000 and 10 cm−1, at a resolu-
tion of 4 cm−1.
Thermogravimetric analysis (TGA) was carried out using a
Q500 (TA Instruments, UK) with nitrogen as an inlet gas. The
analyses were carried out for unfunctionalised thiolated silica,
PEGylated, and POZylated nanoparticles. The instrument was
zeroed against an empty platinum TGA pan (TA Instruments,
UK). Samples were placed into an aluminium DSC pan, before
being placed into the platinum TGA pan, and loaded into the
instrument. The initial temperature was set to 35 °C, and allowed
to equilibrate for 5 minutes. Thermal decomposition of samples
was studied between 35 and 500 °C, at 5 °C min−1 heating rate.
2.7 Characterisation of mucin suspensions
All mucin suspensions used in this study for both diﬀusion
and rheological experiments were prepared by suspending
500 mg porcine gastric mucin in 50 mL deionised water,
resulting in a 1% w/v suspension. Samples were left to stir
overnight at room temperature. Three independent stock solu-
tions were made for triplicate experiments.
Rheological analysis used an AR 2000ex rheometer (TA
Instruments, UK) with a 40 mm parallel plate. Initially,
samples were measured to determine the linear visco-elastic
region at 25 °C, with the solvent trap in place. A fixed fre-
quency of 1 Hz was applied, and the amplitude strain
measured between 0.01 and 50%. Based on these results, an
amplitude of 1% was selected for all remaining experiments.
Following this, a frequency sweep was performed, scanning
between 0.1 and 10 Hz, at a set amplitude of 1% (again at
25 °C with the solvent trap). The final optimal parameters
employed were; an amplitude of 1% and frequency of 0.5 Hz.
These were applied for all remaining rheological experiments.
After the above parameters were defined, a temperature
ramp study was carried out in order to determine the viscosity
over a range of temperatures, to ensure that the sample
remains in the viscoelastic region. Here, the instrument was
set to increase by 1 °C min−1, between 20 and 40 °C. The vis-
cosity was then plotted as a function of time, and the line
equation used to determine the viscosity of the mucin dis-
persion at 25 and 37 °C (Fig. 2s†). Each stock solution was
measured 3 times, for each parameter (amplitude, frequency,
and temperature), resulting in a total of 9 readings.
2.8 Assessing the diﬀusion of nanoparticles in porcine
gastric mucin dispersions using NTA
All diﬀusion measurements were carried out using the Nano-
Sight LM10, with LM14 top-plate and syringe pump. Fluo-
rescent nanoparticles were diluted down by a factor of 10 000
in deionised water. 10 µL of this dilution was then added to a
990 µL suspension of 1% w/v gastric mucus, forming a final
dilution of 1 : 1 000 000.
Samples were injected into the NanoSight system and the
flow-rate was set at 70 AU in order to minimise fluorescent
bleaching of the nanoparticles during analysis. All videos were
recorded through a long pass filter, with a wavelength cut-on
of 550 nm (Thorlabs, UK). 6 × 60 second videos were recorded
at 25 and 37 °C. Each independent stock dispersion of mucin
was analysed three times with each nanoparticle type, result-
ing in a total of 9 × 6, 60 second videos for each temperature,
with a viscosity of 25 cP at 25 °C and 28 cP at 37 °C (as deter-
mined from rheological analyses).
2.9 Ex vivo analysis of nanoparticle diﬀusion through
porcine gastric mucosa
Porcine stomach was obtained from a local abattoir (P.C.
Turner Abattoirs, Farnborough, UK), and dissected to remove
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any connective tissue and muscle, leaving only the mucosa, sub-
mucosa, and stomach lining intact. 4 × 1 cm2 sections were cut
and placed on a glass plate, with the mucosal layer facing
upward. 100 µL of fluorescein labelled nanoparticles were
pipetted onto the sections. Deionised water was also adminis-
tered as a blank control. Samples were left to incubate over 4
time periods; 0, 15, 30, and 45 minutes at room temperature.
Following each time point, each section was placed mucus side
up into a small (3.5 × 5.5 cm) weighing boat (Fisher), half filled
with OCT, a cryoprotective embedding medium. They were then
placed on dry ice, before being completely embedded in OCT to
preserve the particle-loaded mucus membrane. Once all sections
were embedded, samples were left on dry ice for 3–4 hours,
before being transferred to a −80 °C freezer until processing.
For sectioning, samples were removed from the −80 °C
freezer and placed on dry ice. Each sample was mounted onto
a standard solid object holder, 22 mm in diameter using OCT,
and placed on dry ice for 30 min until completely frozen. 30
µm sections were cryosectioned transversely using a standard
189 × 27 × 10 mm blade at 22°, placed onto glass slides (VWR,
UK) and left to dry in air for 30 minutes before being stored in
a slide box. All sections were cut from interior to exterior (i.e.
upwards through the mucosal layer) in order to avoid carriage
of particles into the biological tissue during the cutting
process. All sections were cut using a Bright 5040 cryostat in a
Bright Model PTF freezing chamber at −20 °C (Bright Instru-
ment Co. Ltd, UK).
Sections were placed under a Leica MZ10F stereomicro-
scope (Leica Microsystems, UK) and images taken using an
exposure time of 0.8 ms. All images were taken through an
ET-GFP filter (Leica Microsystems, UK), enabling the particles
to be detectible on the tissue, due to their fluorescent label-
ling. Three images were taken for each section.
ImageJ software (National Institute of Health, USA, v1.43)
was used to quantify penetration of the nanoparticles. For
each image (three for each particle type at each time point);
the background was subtracted, and a line drawn across the
mucus barrier, measuring 1.5 mm in length, and the “plot
profile” measured. This was repeated 5 times at random
locations along the mucus barrier for each image, providing a
total of 15 (3 × 5) profiles for each sample. Each individual
profile was then assessed for the degree of penetration. This
was done by measuring the width of the predominant peak
using Excel 2010. After each profile had been analysed, the
mean values were calculated. The value obtained for the blank
tissue at the appropriate time point was then subtracted from
the other values at the same time point in order to determine
penetration. This method is shown graphically in Fig. 3s.†
2.9 Statistics
In all cases, experiments were repeated 3 times (unless other-
wise stated), and the data presented as mean ± standard devi-
ation. Two-way ANOVA statistical analyses were performed on
GraphPad Prism v5.0 using Tukey’s post hoc test, where p >
0.05 was considered to be statistically insignificant.
3. Results and discussion
3.1 Nanoparticle synthesis and characterisation
In this study PEG and POZ were used to modify nanoparticle
surfaces. PEG has previously been reported to facilitate pene-
tration of nanoparticles into mucosal membranes,27–29 and
hence provided a useful comparator to the POZ-based
enhancement in this study.
Parent thiolated silica nanoparticles were highly mono-
disperse (PDI < 0.15) and carried an abundance of surface
thiol groups, allowing facile surface functionalisation and fluo-
rescent labelling via click reactions. Thiolated nanoparticles
were reacted with 5 kDa maleimide terminated PEG forming a
PEGylated shell as previously reported by our group.15,24 POZy-
lated nanoparticles were prepared using a novel approach, by
reacting thiolated nanoparticles with 5 kDa alkyne terminated
POZ via thiol–yne click-chemistry.
The hydrodynamic sizes of all nanoparticles synthesised in
this study were characterised using DLS and NTA. Fig. 1 shows
the particle size distributions recorded using DLS. NTA data
are shown in Fig. 4s.† Table 1 summarises the physico-
chemical characteristics of all nanoparticles, including particle
size analysis from both DLS and NTA.
Both DLS and NTA are techniques used primarily to deter-
mine the size of nanoparticles but diﬀer in how they deter-
mine particle sizes. DLS uses scattered light to calculate
particle movement under Brownian motion, and employs an
autocorrelation function to determine a diﬀusion coeﬃcient,
based on the refractive index of the sample, through use of the
Stokes-Einstein equation (eqn (1)). Particle sizes can thus be
calculated and averaged based on scattering intensity to gene-
rate a z-average particle size,
Dc ¼ kBT3πηd ; ð1Þ
where Dc is the diﬀusion coeﬃcient, kB is the Boltzmann con-
stant, T is the temperature, η is the viscosity and d is the par-
ticle diameter.
Fig. 1 Dynamic light scattering size distributions of thiolated (blue),
PEGylated (red) and POZylated (green) silica nanoparticles.
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In contrast, NTA measures the movement of individual par-
ticles over a period of time, and plots their x and y coordinates
as pixels, where each pixel represents a specific size. Based on
the number of pixels a particle crosses and the speed at which
they cross, a diﬀusion coeﬃcient can be calculated, dependent
on the viscosity of the system. This diﬀusion coeﬃcient is then
used in the Stokes-Einstein equation (as above) to generate a
particle size.31 By using this tracking technique, it is also poss-
ible to determine the movement and diﬀusion coeﬃcients of
fluorescent nanoparticle suspensions in solutions of polymers
or proteins. Recently we demonstrated the value of NTA to
study the diﬀusive properties of nanoparticles in solutions of
diﬀerent polymers.24
NTA presents particle count (particles per mL) as a function
of size. Based on the concentration values, a particle size dis-
tribution is calculated, showing the population of particles at a
given size. The diﬀerence in concentration evident from the
size distribution from NTA analysis can be explained by the
diﬀerence in dry-weight of the nanoparticles, as demonstrated
in Table 1. This discrepancy is likely due to the fact that the
functionalised particles are less prone to aggregation, and
therefore the actual number of particles per mL of suspension
is lower.
Size data from both DLS and NTA for thiolated, PEGylated
and POZylated silica are in very good agreement and are con-
sistent with expectations; decorating the thiolated nano-
particles with a polymer coating increases their particle sizes.
The physicochemical characteristics of thiolated nano-
particles reported here are in good agreement with our pre-
vious study.24 The particle size and diﬀusion coeﬃcient for
thiolated silica nanoparticles in water are not significantly
diﬀerent for the data reported by Mun et al. (p > 0.05).24 The
size of the particles functionalised with 5 kDa PEG is also
similar to the reported value.
Comparison between the particles synthesised here, and
those reported by Mun et al.,24 shows that the concentration of
free thiol groups for unfunctionalised silica nanoparticles in
this study, and those reported by Mun et al.24 (249 ± 30 μmol
g−1), are in good agreement, as is the free thiol content for
5 kDa PEG (78 ± 5 μmol g−1). This demonstrates that the syn-
thesis is highly reproducible, and produces a monodisperse
suspension of nanoparticles, which can be very eﬀectively and
easily modified using click chemistry.
Further characterisation of nanoparticles was conducted
using FTIR and FT-Raman spectroscopy (Fig. 2 for FTIR). The
FTIR spectrum of thiolated nanoparticles shows the presence
of strong vibrational modes at 2934 cm−1 (asymmetric CH2
stretching), 1108 cm−1 (Si–O–Si asymmetric stretching),
1030 cm−1 (Si–O–Si bending vibration) and 636 cm−1 (Si–S
stretching) and weaker bands at 1404 cm−1 and 1244 cm−1.
Additionally, the Raman spectrum of these particles shows the
presence of strong modes at 2905 cm−1 (asymmetric CH2
stretching), 2562 cm−1 (SH stretching), and 1420 cm−1 (CH2
bending), and weaker bands at 1312 cm−1, 1230 cm−1,
1055 cm−1 (Si–O–Si stretching), 807 cm−1, and 631 cm−1.
The FTIR spectrum of the PEGylated sample shows peaks at
2878 cm−1 (CH2 stretching), 1710 cm
−1 (CvO groups in malei-
mide), 1460 cm−1, 1344 cm−1, 1242 cm−1, 1092 cm−1 (C–O–C
and Si–O–Si stretching vibrations), 840 cm−1 and 692 cm−1.
The appearance of the band at 1710 cm−1 in this spectrum
clearly shows successful conjugation of PEG maleimide to the
surface of the thiolated silica nanoparticles.
POZylated nanoparticles show the presence of the following
peaks in their FTIR spectra: 2940 cm−1 (asymmetric CH2
stretching), 1636 cm−1 (CvO stretching of POZ), 1422 cm−1
(asymmetric vibrations of CH3 groups in POZ), 1110 cm
−1 and
1140 cm−1 (typical for Si–O–Si asymmetric stretching and
bending, respectively). The Raman spectra of POZylated par-
ticles have the following main peaks: 2914 cm−1 (asymmetric
CH2 stretching), 2559 cm
−1 (stretching of unreacted SH groups
of silica nanoparticles), 1649 cm−1 (CvO stretching of POZ),
1448 cm−1 (asymmetric vibrations of CH3 groups in POZ), and
1032 cm−1 (Si–O–Si groups in silica nanoparticles). Thus, both
spectroscopic techniques clearly confirm the presence of PEG
Table 1 Physicochemical characteristics of functionalised and unfunctionalised silica nanoparticles in water. Values shown are the mean ± standard
deviation of three repeats
Sample
Z-Averagea
(nm) PDIa
ξ-Potentiala
(mV)
Modal particle
sizeb (nm)
Diﬀusion coeﬃcient in
waterb (×104 nm2 s−1)
Concentration
(mg mL−1)
Free thiol content
(µM g−1)
Thiolated silica 48 ± 1 0.137 ± 0.050 54 ± 2 47 ± 3 857 ± 78 19 ± 3 229 ± 13
PEGylated silica 70 ± 1 0.175 ± 0.070 24 ± 1 63 ± 2 687 ± 41 13 ± 1 93 ± 13
POZylated silica 56 ± 2 0.130 ± 0.010 37 ± 1 57 ± 2 744 ± 82 7 ± 1 20 ± 11
aDetermined using DLS. bDetermined using NTA.
Fig. 2 FTIR spectra for thiolated (blue), PEGylated (red), and POZylated
(green) silica nanoparticles.
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and POZ on the surface of the PEGylated and POZylated nano-
particles, respectively.
TGA was used in this work to determine the amount of
polymer bound to the nanoparticle surface. TGA thermograms
showing thermal decomposition of each particle type can be
found in Fig. 5s, ESI†). By using the thiolated silica as a refer-
ence sample (i.e. by subtracting the relative weight loss in this
sample from the functionalised particles weight change), it
was found that PEGylated nanoparticles had 69% of PEG
bound, and POZylated nanoparticles had 46% of POZ. Based
on this, it is clear that less POZ has bound to the nanoparticle
surface compared to PEG, most likely due to steric hindrance.
As the 2-ethyl-2-oxazoline repeating unit is significantly
spatially larger than ethylene glycol, a smaller quantity of POZ
will reach the particle surface and be able to bind compared to
PEG. This smaller quantity of bound POZ on the nanoparticle
surface could lead to the smaller particle size (Table 1).
Another reason for the size diﬀerence between PEGylated and
POZylated nanoparticles is the number of repeating units
found in these polymers (50 for POZ, and 113 for PEG). As
ethylene glycol (Mr = 44) is a smaller molecule than 2-ethyl-2-
oxazoline (Mr = 99), the chain length will be longer, thus
leading to a larger particle size.
3.2 Nanoparticle diﬀusion through mucus and stomach
tissue
NTA has previously been reported as a powerful tool to study
the diﬀusion of nanoparticles in aqueous solutions of poly-
mers.24 The use of NTA to study diﬀusion of nanoparticles in
mucin dispersions is more challenging because of intrinsic
fluorescence from this biopolymer. To avoid this interference,
the nanoparticles were labelled with BODIPY, whose fluo-
rescent properties allow diﬀerentiation from those of mucin.
By fluorescently labelling the nanoparticles it is possible to
track their movement without interference from any non-fluo-
rescent species present in the mixture.
Here, the diﬀusion of nanoparticles in the mucin disper-
sions was studied both at ambient (25 °C), and physiological
temperatures (37 °C). Fig. 3 shows the diﬀusion coeﬃcient dis-
tributions for thiolated, PEGylated and POZylated silica nano-
particles in mucin dispersions at 37 °C. Diﬀusion coeﬃcient
distributions recorded at room temperature (25 °C) can be
seen in ESI (Fig. 6s†). The diﬀusion coeﬃcients recorded for
both the functionalised and unfunctionalised nanoparticles in
mucin dispersions were significantly lower (p < 0.05) than
their diﬀusion in deionised water (Table 1). This is due to the
increased viscosity of the mucin suspension compared to
water. The functionalisation of nanoparticles with PEG and
POZ enhances their diﬀusion in mucin dispersions at both
temperatures, as the diﬀusion coeﬃcient distributions of both
PEGylated and POZylated nanoparticles show a clear shift to
higher values compared to that of thiolated nanoparticles.
Fig. 4a shows the mean values for diﬀusion coeﬃcients
recorded for thiolated, PEGylated and POZylated nanoparticles
at 25 and 37 °C. No significant diﬀerence is observed in
diﬀusion coeﬃcients for a given nanoparticle in mucin
measured at 25 or 37 °C (p > 0.1). However, the diﬀusion
coeﬃcient for PEGylated and POZylated silica nanoparticles is
significantly diﬀerent from that of unfunctionalised thiolated
nanoparticles at both temperatures (p < 0.001).
Alongside this, the Stokes-Einstein equation was used to
calculate the theoretical diﬀusion coeﬃcients (Fig. 4b) based
on the particles z-average and standard deviation from DLS
(Table 1). The diﬀusion coeﬃcients for both parent and func-
tionalised nanoparticles measured using NTA are greater than
those calculated using the Stokes-Einstein equation. Devi-
ations between experimentally measured and calculated
diﬀusion coeﬃcients exist when the hydrodynamic radius (Rh)
of the particles is smaller than (or comparable to) the radius of
gyration (Rg) of any polymers present in a liquid medium (solu-
tion or melt).30 If the Rg for the polymer is higher than the Rh
of the particles, then the nanoparticles can ideally move in
between the mesh fibres of the polymer. This means that par-
ticles smaller than the Rg will be exposed to a diﬀerent micro-
environment than particles larger than the Rg, and will
therefore appear to diﬀuse quicker than predicted. However, if
the Rh is higher than the Rg, then the particles will move
around the mesh fibres of the polymer, and so the diﬀusion
coeﬃcient will match that predicted by the Stokes-Einstein
equation.32
In our case, the mucin protein in the dispersions is highly
polydisperse, with particle sizes exceeding 1 μm,33,34 i.e. clearly
much greater than the nanoparticle size used in this study;
therefore the substantial deviation between our measured
diﬀusion coeﬃcients and the predicted values is not
surprising.
In order to correlate the nanoparticle diﬀusion coeﬃcients
in a mucin dispersion to their penetration into a mucosal
tissue, fluorescently-labelled thiolated, PEGylated and POZy-
lated nanoparticles were applied to freshly excised porcine
stomach mucosa. The particles were left in contact with the
tissue for 0, 15, 30 and 45 minutes and were then frozen and
sectioned. Images were then collected using a stereomicro-
Fig. 3 Distribution of diﬀusion coeﬃcients for thiolated (blue), PEGy-
lated (red) and POZylated (green) silica nanoparticles in 1% w/v gastric
mucus at 37 °C. Data represents the mean distributions, where n = 9.
Paper Nanoscale
13676 | Nanoscale, 2015, 7, 13671–13679 This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
Ju
ly
 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
6/
08
/2
01
5 
10
:1
9:
28
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
scope and ImageJ used to quantify the penetration by thio-
lated, PEGylated and POZylated silica (Fig. 7s†), normalised to
a sample with no particles. The results are shown in Fig. 5.
The thiolated nanoparticles show very little penetration into
the gastric mucosa, even following 45 minutes of treatment,
whereas PEGylated and POZylated particles have greater pene-
tration into, and permeation through, the biological tissue.
The enhanced penetration of PEGylated and POZylated
nanoparticles into the gastric mucosa, compared to their thio-
lated counterpart, are in excellent agreement with the data on
their diﬀusivity in mucin dispersions. The better diﬀusivity of
PEGylated and POZylated nanoparticles compared to parent
thiolated particles is related by the “stealth” character of both
polymers that prevents their interaction with the components
of mucus gel.
Mun et al.24 reported on the diﬀusion of particles decorated
with PEG of two diﬀerent molecular weights (750 Da vs. 5000
Da) through a variety of diﬀerent polymer solutions. This
study found that particles with smaller molecular weight PEG
diﬀused quicker than particles with larger PEG chains. This
could explain why in the current study POZylated particles
diﬀuse more readily than PEGylated particles.
In this study, despite both polymers being of the same
molecular weight, the size of POZylated nanoparticles is
smaller compared to PEGylated nanoparticles, which explains
a slower diﬀusion in the latter. This correlates with the data
on the predicted diﬀusion coeﬃcients (Fig. 4): the smaller
POZylated particles have a larger diﬀusion coeﬃcient com-
pared to the PEGylated particles.
It has previously been established that thiolated silica
nanoparticles have mucoadhesive properties and adhere to
bovine cornea due to the formation of disulphide bridges with
corneal mucins.15 Here, these particles show the lowest rate of
diﬀusion in porcine gastric mucin dispersions and also no
significant penetration into gastric mucosa, again probably
related to their ability to adhere to mucins via disulphide
bond formation. It should be noted that the mucin used for
the NTA studies was pre-processed, and may lack some physio-
logical characteristics of fresh mucus (e.g. a reduced amount
of cysteine residues). Additionally, as there are two diﬀerent
mechanisms of diﬀusion being used in this study, namely
diﬀusion through a mucin dispersion, and diﬀusion into a
mucus gel, this discrepancy could be due to the lack of nano-
particle diﬀusion into a gel, whereas they still readily move
around (under Brownian motion) in a gel. This could explain
the diﬀusion coeﬃcient expressed by the thiolated silica in the
NTA study, but no permeation observed in the microscopic
study.
When thiolated particles were PEGylated or POZylated they
acquired “stealth” properties as the thiol groups were masked,
leading to a reduction in their zeta potential. This modifi-
cation resulted in significantly enhanced their diﬀusivity in
mucin dispersions and concomitant increased penetration
into gastric mucosa (Fig. 6).
Here we have demonstrated that the diﬀusive properties of
mucoadhesive nanoparticles can be enhanced by functionali-
sing their surface with either PEG or POZ. PEGylation has pre-
viously been demonstrated to enhance the diﬀusivity of
particles in a mucus gel,12,27–29 however, our study is the first
to report the potential of poly(2-ethyl-2-oxazoline) to facilitate
Fig. 4 Experimentally determined diﬀusion coeﬃcients (a), and calcu-
lated diﬀusion coeﬃcients (b) of functionalised and unfunctionalised
silica nanoparticles through 1% w/v gastric mucus. Data show the mean
± standard deviation, where n = 9.
Fig. 5 Permeation of thiolated, PEGylated, and POZylated silica nano-
particles through porcine gastric mucosa. The values represent the
means of 3 repeats ± standard deviation. All values were subtracted
from values obtained for the blanks. *Represents p < 0.05, **represents
p < 0.01 and ***represents p < 0.005.
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penetration enhancement to a similar degree as that of poly
(ethylene glycol). POZ has several advantages over PEG, most
noticeably the facile polymerisation and modification. POZ
can be readily synthesised via a living cationic polymerisation
method allowing for control of the molecular weight of the
polymer. Additionally, it can be easily modified around a
pendant group attached to the amide, allowing for further
functionalisation, including the potential to bind a drug
forming a pro-drug.35,36 In contrast, PEG polymerisation typi-
cally involves complex synthetic routes and the use of toxic
reactants.20 Additionally, it has been shown that in rats, POZ is
much more readily excreted via the renal route, does not bio-
accumulate and is biodegradable under certain conditions,
whereas PEG can bioaccumulate and form vacuoles in some
organs.17,37
4. Conclusions
We have demonstrated that the diﬀusive properties of muco-
adhesive nanoparticles can be enhanced by functionalising
their surface with either poly(ethylene glycol) or poly(2-ethyl-2-
oxazoline). PEGylation is known to enhance the permeation of
nanoparticles through a mucus barrier, but we show for the
first time that poly(2-ethyl-2-oxazoline) is also able to facilitate
penetration enhancement similar to that of poly(ethylene
glycol). Considering the important benefits that POZ has over
PEG, these results oﬀer advantages in the design and appli-
cation of nanomedicines. We have also developed a novel micro-
scopic approach to probe the penetration of nanoparticles into
ex vivo gastric mucosa and established a very good correlation
between the diﬀusivity of nanoparticles in mucin dispersions,
studied using nanoparticle tracking analysis and their pene-
tration into and permeation through biological tissue.
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